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Abstract
Background: Antimicrobial susceptibility testing of microorganisms is performed by either disc
diffusion or broth dilution tests. In clinical use, the tests are often still performed manually although
automated systems exist. Most systems, however, are based on turbidometric methods which have
well-known drawbacks.
Results: In this study we evaluated isothermal micro calorimetry (IMC) for the determination of
minimal inhibitory concentrations (MICs) of 12 antibiotics for five micro-organisms. Here we
present the data for the 12 antibiotics and two representative microorganisms E. coli (a Gram-) and
S. aureus (a Gram+). IMC was able to determine the MICs correctly according to CLSI values. Since
MICs require 24 hours, time was not reduced. However, IMC provided new additional data – a
continuous record of heat-producing bacterial activity (e.g. growth) in calorimetry ampoules at
subinhibitory antibiotic concentrations. Key features of the heatflow (P) and aggregate heat (Q) vs.
time curves were identified (tdelay and  Q/ t respectively). Antibiotics with similar modes of action
proved to have similar effects on tdelay and/or  Q/ t.
Conclusion:  IMC can be a powerful tool for determining the effects of antibiotics on
microorganisms in vitro. It easily provides accurate MICs – plus a potential means for analyzing and
comparing the modes of action of antibiotics at subinhibitory concentrations. Also IMC is
completely passive, so after evaluation, ampoule contents (media, bacteria, etc.) can be analyzed by
any other method desired.
Background
In order to evaluate antimicrobial susceptibility of micro-
organisms, a variety of methods is available for clinical
laboratories [1,2]. The most commonly used are disc dif-
fusion tests or broth dilution tests. For both methods,
automated systems exist for determination of the minimal
inhibitory concentration (MIC) of an antibiotic for a
microorganism and are in use in clinical laboratories [1].
For broth dilution, the automated systems use different
methods for detection. They either detect growth or non-
growth photometrically, fluorometrically or turbidomet-
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rically [1]. One of the most common used systems is the
Vitek® or Vitek2® which determines growth turbidometri-
cally at hourly intervals for up to 15 h. Turbidity based
methods, however, assume a linear relationship between
test organism growth and absorbance [3]. Also, if turbid-
ity is interpreted visually, results can differ from person to
person.
All chemical or physical processes either generate or con-
sume heat. This can be measured using isothermal micro-
calorimetry (IMC). The heat flow rate is proportional to
the reaction rate, and the total heat produced in some
time t is proportional to the extent of the reaction taking
place in time t. Based on these principles, IMC is a univer-
sal tool for real-time evaluation of rate processes in small
(e.g. 3–20 ml) ampoules, including processes involving
cultured cells [4]. In IMC the net heat flow generated by
any biological or non-biological chemical or physical
processes taking place within the ampoule is continuously
measured while the ampoule is kept at constant tempera-
ture. IMC instruments can be calibrated with an internal
precision heater or with reactions of known heat-flow.
However, the instruments measure the net heat flow pro-
duced by all processes taking place in an ampoule. There-
fore, in order to correctly interpret the measurements, the
user must have knowledge of what processes are taking
place and have, if necessary, an experimental means for
accounting for heat flow from processes not of interest. A
prime example is chemical breakdown of the medium in
which a process of interest is taking place. Besides being a
universal rate process measurement tool, IMC also has the
advantage that it is entirely passive. Therefore the speci-
men is not disturbed in any way during measurement,
and after measurement the contents of ampoule can be
evaluated by any other means desired. More information
is available in a review by Lewis and Daniels (the senior
author) giving a detailed description of the nature, advan-
tages and limitations of IMC, including its use in evaluat-
ing cellular processes involving bioactive materials [4].
In 1996, the senior author began reporting his experience
using isothermal micro-nano calorimetry to evaluate the
activity of cultured cells- response of cultured macro-
phages to implant material particles [5]. However, micro-
calorimetry has been long-used to study metabolism of
cultured cells. James reviewed work in cellular microcalor-
imetry in 1987 [6] and reported a paper by Hill in 1918 as
the earliest employing microcalorimetry to study bacteria.
In 1977, Ripa et al. [7] evaluated microcalorimetry as tool
for the evaluation of blood culture media. In the study,
the influence of additives on blood culture could be deter-
mined much faster and easier compared to traditional
media evaluation methods. Based on their data, Ripa et al.
[7] suggested the use of microcalorimetry as tool to evalu-
ate the inhibitory or stimulatory influence of various com-
pounds.
Later, another study used microcalorimetry to detect the
growth of microorganisms [8]. Other studies described
the use of microcalorimetry to evaluate the antimicrobial
actions of propiolis extracts [9] or selenium on bacterial
strains [10]. Antoce et al. [11] successfully used calorimet-
ric methods for the determination of inhibitory effects of
alcohols on yeasts to avoid computational errors based on
direct assessment of bioactivity using turbidity. An impor-
tant feature of this method was first noted in the study of
Garedew et al. [12]: microcalorimetry can provide rapid
detection of bacterial growth. If the number of bacteria in
a calorimeter ampoule rise to about 104 cfu they can be
detected by their heat production. If growth continues, the
heat flow rate will continue to rise for some time.
This was used to advantage in our laboratory in a recently
published study in which we employed isothermal micro-
calorimetry for rapid detection of MSSA and other micro-
organisms in blood products, i.e. platelet concentrates
[13]. Still more recently, we also successfully determined
the MIC of cefoxitin for a MRSA strain and a MSSA strain
[14]. However, IMC did not decrease the time for MIC
determination because MICs are based on detection of
growth at 24 hours. But more importantly, IMC with
media containing added antibiotic concentrations pro-
vided a means for rapidly differentiating between MRSA
and MSSA. In addition, it was apparent that the nature of
the heatflow curves at subinhibitory concentrations of the
antibiotic might provide new insights into the way in
which antibiotics affect growth rates. Therefore, we con-
ceived this study.
To further evaluate IMC we have now determined the
MICs of 12 antibiotics for reference strains of five organ-
isms,  E. coli ATCC25922,  S. aureus ATCC29213,  Pseu-
domonas aeruginosa ATCC27853,  Enterococcus faecalis
ATCC29212, and Streptococcus agalactiae ATCC27956. In
the interest of brevity we report here only the results for E.
coli ATCC25922 and S. aureus ATCC29213 as representa-
tives for Gram- and Gram+ bacteria, respectively.
Results
As is evident in Figs. 1, 2, 3, 4, 5 and 6, the heat flow rate
signals from blank ampoules (no inoculum) never
departed appreciably from baseline over the time of meas-
urement. That is, the blanks produced no appreciable heat
flow – especially compared to the peak values (often >
100 μW) measured when bacteria were present. Thus all
heat flow signals above baseline could be attributed to
bacterial activity and growth. Table 1 provides an over-
view comparing the MICs determined by IMC with those
determined by a standard turbidometric method. It also
provides a comparison of key growth-related calorimetric
parameters determined at subinhibitory concentrations
just below the MIC value: tdelay (delay in time of onset of
detectable heat flow), and Pmax (maximum rate of heatBMC Microbiology 2009, 9:106 http://www.biomedcentral.com/1471-2180/9/106
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production). These and other calorimetric parameters per-
tinent to this study and derived from the data are
explained and used in the Discussion section.
MICs for E. coli ATCC25922
We evaluated the MICs of 12 different antibiotics for E.
coli. For brevity, we present here the results for 7 antibiot-
ics grouped by mode of action. The antibiotics used and
their concentrations can be found in the corresponding
figures. All evaluations were also performed in parallel
using the standard method – visual detection of turbidity
at 24 hours. Unless otherwise stated, the results for the
MIC determination were the same for calorimetry and the
standard visual method. In Figs. 1, 2, 3, 4, 5 and 6, Col-
umn A shows the recorded heat flow rate data (μW = μJ/s
vs. time in min.). Any time delay (tdelay) before a heat sig-
nal was recorded was the time required until there were
sufficient numbers of active bacteria to produce a heat
flow signal above the instrument's detection limit. The
highest peak in a μW vs. time curve indicates the maxi-
mum rate of heat production observed (Pmax). Column B
presents the results of integrating the data in Column A to
show the cumulative amount of heat produced over time
(J vs. time in min.). As explained later, the Column B
curves are somewhat analogous to conventional growth
curves showing the increase in the number of bacteria
over time. Mean slopes ( Q/ t) for a given portion of an
aggregate heat curve are aggregate rates of heat production
and indicative of their rate of bacterial growth. Maximum
values (Qmax) are related to the total numbers of cells pro-
duced by time t.
E. coli and cephalosporines of the 1st and 2nd generation.
(Fig. 1). The 1st generation cephalosporine used in this
Heatflow data (column A) and resultant cumulative heat curves (column B) for IMC determinations of the MICs of the respec- tive cephalosporines for E. coli ATCC25922 incubated at 37°C Figure 1
Heatflow data (column A) and resultant cumulative heat curves (column B) for IMC determinations of the 
MICs of the respective cephalosporines for E. coli ATCC25922 incubated at 37°C. Culture medium was cation-
adjusted Mueller-Hinton II broth. t1, t2: tdelay for 0 mg l-1 antibiotic; t3: tdelay for 4 mg l-1 cefoxitin. Blank is medium alone. Curves 
are the mean of three replicates.BMC Microbiology 2009, 9:106 http://www.biomedcentral.com/1471-2180/9/106
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Heatflow data (column A) and resultant cumulative heat curves (column B) for the IMC determinations of the MICs of ampicil- lin, piperacillin and aztreonam for E. coli ATCC25922 using IMC Figure 2
Heatflow data (column A) and resultant cumulative heat curves (column B) for the IMC determinations of the 
MICs of ampicillin, piperacillin and aztreonam for E. coli ATCC25922 using IMC. Experiments were performed in 
cation-adjusted Mueller-Hinton II broth at 37°C. t1, t2, t4: tdelay for 0 mg l-1 antibiotic; t3: tdelay for 2 mg l-1 piperacillin; t5: tdelay for 
0.125 mg l-1 aztreonam. Blank is medium alone. Curves are the mean of three replicates.BMC Microbiology 2009, 9:106 http://www.biomedcentral.com/1471-2180/9/106
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study was cefazolin and its MIC for E. coli was correctly
determined using IMC as 2 mg l-1 based on the recom-
mendations of the CLSI [15]. At the MIC and higher con-
centrations there was essentially no growth. However,
there was a slight temporary increase in heatflow at the
beginning of the experiments. This suggests a slight tran-
sitory increase in metabolic activity of the bacteria
present, followed by no subsequent growth. At all subin-
hibitory concentrations, heat production of E. coli was the
same (same tdelay, Pmax,  Q/ t, and Qmax).
Cefoxitin was used as an antibiotic representing the 2nd
generation of cephalosporines although it is a member of
a subgroup of this generation and also active for anaerobic
bacteria. The cefoxitin MIC could also be determined cor-
rectly using IMC as 8 mg l-1. In contrast to cefazolin, there
was no transient initial increase in heatflow at the MIC
(Fig. 1A).
Also, the profiles of the curves at subinhibitory concentra-
tions differed markedly between cefazolin and cefoxitin
(Fig. 1). For cefoxitin, tdelay  (Fig. 1A) increased with
increasing concentration, and antibiotic tended to lower
Pmax. Also initial  Q/ t  values (Fig. 1B) declined with
increasing antibiotic concentration, but Qmax tended to a
maximum value (~9 J) independent of antibiotic concen-
tration. The calorimetric method thus highlighted differ-
ences in action of the two cephalosporines.
E. coli and penicillins. (Fig. 2). Ampicillin and piperacillin
were tested as members of the penicillin family. Addition-
ally, the monobactam aztreonam was included in this
group, because it is another antibiotic interacting with cell
wall synthesis but with a different mode of action. The
grouping with ampicillin and piperacillin also facilitated
a comparison of the curve profile differences. For ampicil-
lin, the MIC could not be determined by either method
Heatflow data (column A) and resultant cumulative heat curves (column B) for the IMC determinations of the MICs of amikacin  and gentamycin for E. coli ATCC25922 in cation-adjusted Mueller-Hinton II broth incubated at 37°C Figure 3
Heatflow data (column A) and resultant cumulative heat curves (column B) for the IMC determinations of the 
MICs of amikacin and gentamycin for E. coli ATCC25922 in cation-adjusted Mueller-Hinton II broth incubated 
at 37°C. t1, t3: tdelay for 0 mg l-1 antibiotic; t2: tdelay for 2 mg l-1 amikacin; t4: tdelay for 0.5 mg l-1 gentamycin. Blank is medium 
alone. Curves are the mean of three replicates.BMC Microbiology 2009, 9:106 http://www.biomedcentral.com/1471-2180/9/106
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with the range of concentrations used, although a
decrease in heatflow could be detected for 8 mg l-1. For
piperacillin, the MIC for E. coli was determined as 4 mg l-
1 which corresponds to the value for quality control in the
CLSI manual [15]. At the beginning of the experiment, a
slight transient increase of the heatflow curve was detected
at the MIC as well as on the delayed heatflow curve for a
concentration of 2 mg l-1 piperacillin (Fig. 2). The MIC for
aztreonam was "on the edge" of determination as 0.25 mg
l-1 using standard methods (OD600 0.06). However, the
results of IMC show that the MIC was higher, and the
tested concentrations were too low (Fig. 2).
As discussed above, the concentrations of ampicillin were
too low to provide much information. However, at 8 mg
l-1 Pmaxdecreased. The profiles of the heatflow curves were
similar for piperacillin and aztreonam and (Fig. 2A). The
heatflow curve at the highest subinhibitory concentration
of aztreonam (0.25 mg l-1) had a higher tdelay than the one
for piperacillin (2 mg l-1) – roughly 950 min vs. 445 min.
As is generally the case, antibiotics tended to lower Pmax.
For the heat curves (Fig. 2B) the initial  Q/ t  values
declined with increasing antibiotic concentration, but the
effect was stronger for aztreonam. As before, Qmax values
tended toward a maximum of 9–10 J not related to antibi-
otic concentration.
E. coli and bacterial protein synthesis inhibitors. (Fig 3.)
Two antibiotics inhibiting bacterial protein synthesis were
evaluated, amikacin and gentamycin. For gentamycin, the
MIC was determined as 1 mg l-1 which is in concordance
with the reference MIC as proposed by the CLSI manual
[15]. For amikacin, the MIC could not be determined with
the tested concentration range by either method. For IMC,
Heatflow data (column A) and resultant cumulative heat curves (column B) for the IMC determinations of the MICs of cefoxitin  and vancomycin for S. aureus ATCC29213 Figure 4
Heatflow data (column A) and resultant cumulative heat curves (column B) for the IMC determinations of the 
MICs of cefoxitin and vancomycin for S. aureus ATCC29213. Cultures were incubated at 37°C in cation-adjusted Muel-
ler-Hinton II broth. t1, t3: tdelay for 0 mg l-1 antibiotic; t2: tdelay for 16 mg l-1 cefoxitin; t4: tdelay for 0.5 mg l-1 vancomycin. Blank is 
medium alone. Curves are the mean of three replicates.BMC Microbiology 2009, 9:106 http://www.biomedcentral.com/1471-2180/9/106
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Heatflow data (column A) and resultant cumulative heat curves (column B) for the IMC determinations of the MICs of chlo- ramphenicol, erythromycin and tetracycline for S. aureus ATCC29213 Figure 5
Heatflow data (column A) and resultant cumulative heat curves (column B) for the IMC determinations of the 
MICs of chloramphenicol, erythromycin and tetracycline for S. aureus ATCC29213. Experiments performed in cat-
ion-adjusted Mueller Hinton II broth at 37°C. t1, t4, t7: tdelay for 0 mg l-1 antibiotic; t2: tdelay for 4 mg l-1, t3: tdelay for 8 mg l-1 chlo-
ramphenicol; t5: tdelay for 0.125 mg l-1, t6: tdelay for 0.25 mg l-1 erythromycin; t8: tdelay for 0.125 mg -1 tetracycline. Blank is medium 
alone. Curves are the mean of three replicates.BMC Microbiology 2009, 9:106 http://www.biomedcentral.com/1471-2180/9/106
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after approx. 1100 min (~18 hours) the heatflow curve of
the highest concentration of 4 mg l-1 started to increase.
The growth of E. coli at this concentration was also con-
firmed using the standard method, resulting in an OD600
of 0.2 for the samples in the calorimeter and 0.7 for the
samples in the water bath.
The profiles of the heatflow and heat curves at subinhibi-
tory concentrations, however, were similar for both anti-
biotics: For heatflow (Fig. 3A) tdelay  increased with
increasing concentration, and Pmax  decreased. For heat
(Fig. 3B), there was virtually no effect on  Q/ t. As before,
Qmax tended to a value of 9–10 J independent of whether
an antibiotic was present. The calorimetric data thus sug-
gest the modes of action of amikacin and gentamycin on
E. coli are essentially the same.
MICs for S. aureus ATCC29213
For S. aureus we determined the MICs of 10 of the 12 anti-
biotics using IMC. However, for the sake of brevity and to
illustrate the main findings, we only present 6 antibiotics
which have the same modes of action as those presented
Heatflow data (column A) and resultant cumulative heat curves (column B) for the IMC determinations of the MICs of cipro- floxacin for S. aureus ATCC29213 in cation-adjusted Mueller-Hinton II broth incubated at 37°C Figure 6
Heatflow data (column A) and resultant cumulative heat curves (column B) for the IMC determinations of the 
MICs of ciprofloxacin for S. aureus ATCC29213 in cation-adjusted Mueller-Hinton II broth incubated at 37°C. 
t1: tdelay for 0 mg l-1 antibiotic; t2: tdelay for 0.25 mg l-1 ciprofloxacin. Blank is medium alone. Curves are mean of three replicates.
Table 1: Overview of the comparison of the broth dilution method as described by the CLSI [15] and the IMC method developed in 
this study.
MIC (CLSI) [mg l-1] MIC (IMC) [mg l-1] tdelay [min] Pmax [μW]
E. coli
Cefazoline 2 2 54 666
Cefoxitin 8 8 402 174
Ampicillin n. d.a n. d. 0 454
Piperacillin 4 4 445 237
Aztreonam n. d. n. d. 950 57
Amikacin n. d. n. d. 1145 o. t.b
Gentamycin 1 1 560 486
S. aureus
Cefoxitin 4 4 412 80
Vancomycin 1 1 147 339
Chloramphenicol 16 16 630 o. t.
Erythromycin 0.5 0.5 638 27
Tetracycline 0.25 0.25 330 27
Ciprofloxacin 0.5 0.5 1097 17
(almost o. t.)
tdelay and Pmax show the values of the curves determined at one concentration below the MIC value.
a n. d.: not determinable using the tested concentrations.
b o. t.: Outside measuring time.BMC Microbiology 2009, 9:106 http://www.biomedcentral.com/1471-2180/9/106
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for E. coli. The tests were also performed in parallel in a
water bath and evaluated using the standard visual turbid-
ity method. Again, unless otherwise stated, the results of
both methods were in agreement with each other.
S. aureus and cell wall synthesis inhibitors. (Fig. 4) The
antibiotics evaluated were cefoxitin and vancomycin. For
cefoxitin, the MIC was determined as 4 mg l-1 whereas
vancomycin had a MIC of 1 mg l-1. Both values were in
agreement with the reference MIC in the CLSI manual
[15].
For both antibiotics, the tdelay  values for the heatflow
curves (Fig. 4A) increased with increasing concentration,
but the effect was stronger for cefoxitin. Also Pmax was
reduced at the highest concentration not inhibiting
growth. For the heat curves (Fig. 4B) there was little
change in  Q/ t with antibiotic concentration. However
Qmaxdeclined, but as shown, the highest value observed
was ~5 J. This is far below the maximum value of 9–10 J
seen repeatedly for E. coli, independent of antibiotic con-
centration, and differences here can be attributed to differ-
ences in tdelay. Thus the chief difference shown by IMC was
the stronger effect of cefoxitin on initial bacterial activity.
S. aureus and protein synthesis inhibitors. (Fig. 5) The
MICs were determined as 16 mg l-1, 0.5 mg l-1 and 0.25 mg
l-1 for chloramphenicol, erythromycin and tetracycline,
respectively, which are identical to the values in the CLSI
manual [15]. The overall profiles of the subinhibitory
heatflow curves (Fig. 5, column A) and heat curves (Fig. 5,
column B) were remarkably similar for all three antibiot-
ics. None of the three antibiotics produced a substantial
increase in tdelay. The only substantial difference was for
the maximum heatflow rate, Pmax. Tetracycline had a
much larger influence on Pmax than the other two antibiot-
ics. All three antibiotics produced a decline in  Q/ t with
increasing concentration. Changes in Qmax with concen-
tration can be attributed to the differences in  Q/ t. The
IMC data suggest that all three antibiotics affect the rate of
bacterial growth but do not delay its onset.
S. aureus and an antibiotic acting on DNA. (Fig. 6) Only
one antibiotic was tested which interacts with bacterial
DNA, namely ciprofloxacin. The MIC was determined as
0.5 mg l-1 using IMC which corresponds to the reference
value in the CLSI manual [15].
For ciprofloxacin, there was no increasing tdelaywith
increasing concentration (Fig. 6A) except for the concen-
tration one level below the MIC. However, the maximum
heatflow rate Pmax decreased with increasing concentra-
tion. For aggregate heat (Fig. 6B)  Q/ t  declined with
increasing concentration. The effect of ciprofloxacin con-
centration on Qmax can be attributed almost entirely to its
effect on growth rates. In summary, IMC data suggest that
ciprofloxacin delayed onset of bacterial growth somewhat
but its principle action was to decrease the rate of subse-
quent growth.
Discussion
In this paper, we present results for the use of isothermal
microcalorimetry (IMC) as tool for the determination of
the minimal inhibitory concentration (MIC) of different
antibiotics on Escherichia coli ATCC25922 and Staphyloco-
ccus aureus ATCC29213 and the effects of subinhibitory
concentrations on the nature of growth. We have already
shown previously that IMC allows the differentiation of
MRSA from MSSA [14], and Antoce et al. used IMC to
determine the inhibitory effect of C1-C4 n-alcohols on the
growth of yeast species [11]. The same group concluded
that if the heatflow curves of the calorimetric measure-
ment are delayed and no change in slope could be deter-
mined, the inhibitory compound is only bacteriostatic –
acting by reducing the initial bacterial cell count. A 1978
study by Semenitz [16] measured the MIC's of olean-
domycin and erythromycin against S. aureus. He used an
early "flow calorimeter" and its resolution was not at the
same level as the sealed-ampoule calorimeters used in this
study. He also mistook suppression of a second growth
peak as evidence of the determination of an MIC.
Cases in which MICs were not determined. In some of our
experiments shown here, we were not able to determine
the MIC value. Nevertheless, we included those results in
this study to show that even if the MIC would be higher
than the tested concentrations, IMC allows conclusions
on the mode of action of antibiotics and to a certain extent
an estimation on the MIC. For amikacin, for example, the
MIC was higher than the tested concentrations in this
study (Fig. 3). However, at a concentration of 4 mg l-1 ami-
kacin, growth started only after approximately 1080 min.
Therefore one can estimate that 8 mg l-1 amikacin would
produce no growth in 24 hours and would thus be the
MIC in this case.
We suggest that the reason why the MIC could not, in
some cases, be determined in accord with the CLSI man-
ual was not due to use of IMC but rather due to the prep-
aration of the samples. First, we found no discrepancies
between results for IMC and the standard turbidity
method. Furthermore, according to the CLSI manual,
causes for differing MICs can include altered activity of the
antibiotics solution, change in inoculum activity or size,
and culture environment factors [15]. In the case of ami-
kacin, it was most likely a reduced activity of the antibiotic
due to wrong handling during delivery (uncooled). We
also had no results by either method for another bacte-
rium tested (data not shown).BMC Microbiology 2009, 9:106 http://www.biomedcentral.com/1471-2180/9/106
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Key features of IMC data at subinhibitory concentrations
of antibiotics. For subinhibitory concentrations of antibi-
otics, IMC provides a detailed record of heat production
related to bacterial activity including growth. The heat
flow and heat curves show that heat-producing activity is
far from constant, and suggest that the curves are potential
"signatures" for a given bacteria, growth medium and
antibiotic that also may help us understand antibiotic
modes of action. The following key features of the heat-
flow (P vs. t) and aggregate heat (Q vs. t) curves are used
in the subsequent discussion of our results:
Delay in time of onset of detectable heat flow. (tdelay)
Detectable heat flow means there are a sufficient number
of active bacteria to produce a heat signal above the
instrument's detection limit. If the initial number of bac-
teria present does not produce detectable heat, then sub-
sequent detection of a heat signal essentially constitutes
detection of increased bacterial activity potentially includ-
ing growth. For the initial bacterial concentrations used
here, some bacteria exhibit a tdelay which is a function of
antibiotic concentration. A clear example of an antibiotic
producing a tdelay alone is the effect of Cefoxitin on E. coli.
The effect can be seen in either the heat flow rate (Fig. 1A)
or cumulative heat data (Fig. 1B). Agents which produce
delays in onset of growth are generally termed "bacterio-
static." Thus for a given growth environment and initial
bacterial concentration, tdelay values could be used to com-
pare levels of bacteriostatic activity.
Maximum rate of heat production (Pmax). In all examples
presented here, a transient maximum rate of heat produc-
tion Pmax was observed. In many of the examples, the mag-
nitude of Pmax  declined as a function of increasing
subinhibitory antibiotic concentration. The effect of Ami-
kacin on E. coli is a clear example (Fig. 3A), as is the effect
of Chloramphenicol on S. aureus (Fig. 5A). In some cases
there was also a substantial second transient maximum of
lower value (See Fig. 1A, E. coli and Cefazolin and Fig. 4A,
S. aureus and Vancomycin). The value Pmax is the aggregate
rate of heat production of all bacteria present at the time
when the maximum occurs. It depends on both the
number of active bacteria present at that time, and the rate
at which each bacteria present is producing heat at that
time. A separate measurement of the number of bacteria
present would be needed in order to use the result to
determine the mean heat production per bacterium at the
time of the maximum. So while the "P max effect" is inter-
esting as part of the "signature" of the thermodynamic
response of bacteria to antibiotics, it is not possible to tell
whether the antibiotic is affecting the number of bacteria
present, their mean rate of heat production or both. One
possibility is that Pmax peaks are due at least in part to
"energy spilling" – transient production of "excess" heat
in processes other than growth or maintenance of cell via-
bility [17].
Rate of aggregate heat production. ( Q/ t). In preliminary
studies (data not shown) we have found that in general
the aggregate heat Q at any time t is related to the number
of bacteria present, and thus that the change  Q/ t for a
given portion of the Q vs. t data is roughly proportional to
the rate of bacterial growth during the time  t. A clear
example of an antibiotic producing change in  Q/ t alone
as a function of antibiotic concentration is the effect of
Chloramphenicol on S. aureus at times up to ~900 min-
utes (Fig. 5B). Antibiotics which change  Q/ t as a function
of their concentration could be called "growth rate inhib-
itors."
Maximum aggregate heat Q at time t. (Qmax) Fig. 5B (S.
aureus, Chloramphenicol) also provides a clear example
of this key feature. In this case differences in Qmaxas a func-
tion of concentration are clearly related to differences in
growth rate as measured by  Q/ t. However, our IMC
method employs sealed ampoules which thus have fixed
initial amounts and types of liquid medium and gas mix
in the headspace, fixed total volume, and no means of
removing products of bacterial activity. Thus there is a
limit to the amount of heatproducing bacterial activity
(including growth) which can take place. Therefore if suf-
ficient time elapses, the Pmax values tend back toward base-
line and the related Qmax values tend to reach the same
maximum value for all subinhibitory antibiotic concen-
trations of a given antibiotic. This is clearly seen for S.
aureus and Cefazolin (Fig. 1, Column B). Looking at the
data in Fig. 5 for S. aureus alone (i.e., 0 mg l-1 Choram-
phenicol) one can see that at about 900 minutes, aggre-
gate heat production Q  is slowing and starting to
approach a maximum.
Therefore, we conclude that the value of Q at any time t
depends on whether the bacteria are still active or whether
activity is either becoming increasingly limited by the
sealed-system environment or has finally ceased. In fact,
our results suggest that the ultimate value of Qmax is strictly
related to the closed system used and is not different for
different antibiotics. Figs 1, 2 and 3 show data for 7 differ-
ent antibiotics for E. coli. All exhibit maximum values of
Q, and the values were all approximately 9–10 J, regard-
less of which antibiotic was employed. Thus it does not
appear that Qmax provides much information regarding
antibiotic effects – except as another way to express the
information contained in  Q/ t at a given place in the time
history.
Using IMC data to compare modes of action. By using the
above key features of all heatflow and aggregate heat
curves of the antibiotics for a single bacterium, it is possi-
ble to quite an extent to group the antibiotics by their
modes of action. This is best illustrated by examining the
results for S. aureus (Fig. 4, 5 and 6). Effects on growth for
antibiotics interacting with cell wall synthesis (Fig. 4)BMC Microbiology 2009, 9:106 http://www.biomedcentral.com/1471-2180/9/106
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were completely different from those interacting with pro-
tein synthesis (Fig. 5) and DNA synthesis (Fig. 6). Within
those groups, there were also slight differences in the
curves which are most likely related to the power of the
antibiotic against the tested strain or a different interac-
tion site.
Cell wall synthesis inhibitors (Fig. 4) seemed to have
mainly a bacteriostatic effect on S. aureus. Onset of detect-
able growth-related activity was delayed, but the subse-
quent rate was little affected by antibiotic concentration.
This was especially evident for cefoxitin. The antibiotics
interacting with cell wall synthesis of S. aureus delay onset
of detectable activity (increase tdelay) and reduce the maxi-
mum rate of heat-producing activity (Pmax), but they don't
change the subsequent rate of increase ( Q/ t) curves (rate
of growth). So any reduction in the maximum amount of
activity (Qmax) that has occurred by a given time is due to
tdelay.
The difference in the mode of action of the two antibiotics
can also be seen. Vancomycin has a unique mode of
action inhibiting the second stage of cell wall synthesis
whereas cefoxitin has the same mode of action as beta-
lactam antibiotics such as penicillins [18-20]. The tdelay
with vancomycin was much shorter for the concentration
just below the MIC than for cefoxitin (Fig. 4A). For cefox-
itin, the concentration range was too high. The highest
concentration should have been 2 mg l-1. However, based
on the data for vancomycin and for cefoxitin on E. coli
(Fig. 1), it can be supposed that tdelay would again decrease
with decreasing concentrations of cefoxitin. This assump-
tion is also strengthened by our results for other bacteria
with cefoxitin (data not shown). Further investigation
would make it clear whether antibiotics inhibiting
transpeptidases and carboxpeptidases such as cefoxitin
have a stronger effect than those interacting with the cell
wall peptidoglycans [20].
In contrast, antibiotics related to protein synthesis in S.
aureus  (Fig. 5A) both delayed the onset of detectable
growth and reduced the subsequent growth rate as a func-
tion of concentration. Tetracycline, which acts on the 30S
ribosome by inhibition of the delivery of charged tRNA
molecules [20], showed a stronger inhibition than either
erythromycin or chloramphenicol, as the decrease was
much greater. On the other hand, erythromycin was less
strong than chloramphenicol. Both act on the 50S ribos-
ome but on different sites.
Erythromycin acts on the association of peptidyl-tRNA
with the P-site whereas chloramphenicol inhibits the pep-
tidyltransferase [20]. These results suggest that IMC might
be a powerful tool to evaluate differences in the potency
of changes in antibiotic concentration for antibiotics act-
ing against protein synthesis. However, further studies
would be needed to validate this suggestion.
In this study, we only tested one antibiotic interacting
with DNA synthesis for S. aureus (Ciprofloxacin, Fig. 6).
Therefore, it's not possible to generalize on an IMC profile
characteristic of this group of antibiotics. However, based
on the experiments above, there are strong indications
that this would be possible. As described above, cipro-
floxacin, as a member of this group, has a large effect on
Pmax but only slightly reduces  Q/ t (Fig. 6). However, 0.25
mg l-1 ciprofloxacin, which is one dilution above the MIC,
had a more dramatic effect on the growth of S. aureus than
other antibiotics with the same level of dilution tested.
This might be related to the mode of action of cipro-
floxacin which is inhibition of the gyrasecatalysed super
coiling [20,21].
The antibiotics interacting with the cell wall synthesis of
E. coli could be grouped into three groups based on their
heatflow curve profile which, however, were not related to
the class of antibiotics (Fig. 1 and Fig. 2).
It was possible to differentiate classic cephalosporines
from 2nd generation cephalosporines based on their pro-
file (Fig. 1) although both have the same working mecha-
nism [20]. Subinhibitory concentrations of cefazolin had
almost no effect on the heatflow curves compared to
cefoxitin (Fig. 1A). It would be interesting to see, whether
a 3rd generation cephalosporine has as well another pro-
file.
By comparing the IMC curves of cefoxitin with E. coli (Fig.
1) and S. aureus (Fig. 4) it can as well be seen that the pro-
file is different for different bacterial species. In this case,
it is even more evident since the cell wall is built up differ-
ently for E. coli (Gram- bacterium) and S. aureus (Gram+
bacterium). However, the same effect can be seen on other
bacteria of the same type of (data not shown).
Interestingly, the heatflow profiles for piperacillin and
aztreonam were very similar (Fig. 2). However, piperacil-
lin had a stronger inhibitory effect on E. coli growth than
aztreonam. In contrast to other antibiotics sharing the
same heatflow profile, the heat curves of E. coli incubated
with aztreonam or piperacillin were different. It seems
that aztreonam has as well an effect on the growth rate at
a later stage during incubation (Fig. 2B). This correlates
partly with the heat curves of E. coli with cefoxitin (Fig.
1B). According to Georgopapadakou et al. [22] aztreonam
has a similar mode of action as cephalosporines which
would explain the similarity in the heat curves.
According to the IMC results, the MIC of aztreonam for E.
coli was higher than 0.25 mg l-1. This was somewhat con-BMC Microbiology 2009, 9:106 http://www.biomedcentral.com/1471-2180/9/106
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firmed by measuring an OD600 value of 0.05 at the end of
incubation. By visual interpretation, the MIC would have
been chosen as 0.25 mg l-1. It seems that the slight increase
in the heatflow curve of E. coli with 0.25 mg l-1 aztreonam
after 950 min might be related to transient initial growth-
related activity of the bacteria before aztreonam begins
having an effect (as can be seen as well for other antibiot-
ics in this group) which causes the heatflow to decrease
after additional 300 min (Fig. 2A).
It was expected that ampicillin and piperacillin would
show similar effects on the heatflow curves at subinhibi-
tory concentrations. However, this was not the case (Fig.
2A). Although it was not possible to determine the MIC
for ampicillin, one can see that 8 mg l-1 ampicillin only
decreased Pmax and had no effect on the detection time for
bacterial activity, in contrast to piperacillin. It is an indica-
tion that E. coli metabolism reacts differently with each of
the antibiotics. Further analysis of this difference was
beyond the scope of this study.
Amikacin and gentamycin are both aminoglycosides act-
ing on the 30S ribosome by inhibition of the transloca-
tion of the growing polypeptide chain from the A to the P
site [20]. The same mode of action is clearly demonstrated
in the profile of the IMC heatflow curves (Fig. 3A). There
are only minor differences between the heatflow curves
which may mostly reflect variations introduced by man-
ual preparation of the samples. The heat curves, however,
differ a bit more (Fig. 3B). This was most likely due to a
reduced activity of the amikacin used as evidenced by
finding an MIC above the recommendations of the CLSI
[15]. It would be interesting to see whether antibiotics
interacting with protein synthesis but with another site of
action (like chloramphenicol on S. aureus) could also be
differentiated as is the case for S. aureus (see above).
Conclusion
We were able to show that isothermal microcalorimetry
could be a powerful tool for MIC determination of antibi-
otics for any cultivable bacterium. There was no time sav-
ing possible since MICs were based on the conventional
approach – evidence of growth at 24 hours. However, it is
clear that determining MICs by IMC has the added advan-
tage of allowing detailed comparative evaluation of the
effects of subinhibitory antibiotic concentrations on
growth-related thermodynamic activity of bacteria.
Furthermore, our study showed that the results are in
agreement with the tests performed with a standard
method by CLSI (broth dilution method). We summa-
rized the results in Table 1 to provide an easy comparison
with the addition tdelay  and  Pmax  of one concentration
below the MIC to show how calorimetry data indicate the
mode of bacterial action.
It might be possible to use an IMC approach to reduce the
time for MIC determinations. For example, one might be
able to develop a method to analyze the first few hours of
IMC data for a series of antibiotic concentrations mathe-
matically and extrapolate the MIC value. Also, by know-
ing the dissociation constant of an antibiotic, it would be
possible to quantitatively characterize the inhibitory effect
using the methods described in the study of Antoce et al.
[11]. This might allow help extrapolation to the MIC
value for a given antibiotic.
It seems likely that IMC studies of the type described here
could be useful in antibiotic research and development.
Early-stage IMC "screening" evaluations could help evalu-
ate the mode of action of any new antimicrobial com-
pound through comparison with known IMC profiles for
the same type and strain of microorganism. The efficacy of
compound modifications could be quickly screened by
comparing new results with those for earlier formulations.
IMC studies of bacterial activity may also be of use in
assessing the effects of phenotypic, genomic and pro-
teomic modifications of microorganisms [23].
Overall, IMC has great power for microorganism activity
studies, due to its high reproducibility and ability for
simultaneous independent, quantitative evaluation of
multiple samples at a given common temperature (e.g. 48
samples in the instrument used). Also, since IMC is com-
pletely passive, specimens are undisturbed, and after any
period of IMC measurement, the ampoule contents
(media, bacteria, etc.) can be analyzed by any other
method desired. Finally, the continuous IMC data are
amenable to mathematical treatment, and the IMC tech-
nique generally lends itself to future automation.
Methods
Isothermal microcalorimetry (IMC)
A TAM 48 (Thermal Activity Monitor 48, TA Instruments,
Lukens Drive, New Castle, DE) was used. This instrument
is designed for parallel multi-sample experiments with 4
ml ampoules. It is comprised of a thermostat containing
48 separate calorimeters which the thermostat maintains
at a selected constant temperature. The individual calo-
rimeters each have a dynamic range ± 50 mW, the short-
term noise is less than ± 100 nW, the baseline drift/24 h is
less than ± 200 nW.
In this study 4 ml ampoules were filled with 2.97 ml of
growth media containing either no antibiotic or a known
amount (details below) plus 0.030 ml of a bacterial inoc-
ulum (details below). Each ampoule was sealed from the
environment and put individually into one of the 48 cal-
orimeters, which were already equilibrated at 37°C and
maintained at 37°C by the thermostat's control system.BMC Microbiology 2009, 9:106 http://www.biomedcentral.com/1471-2180/9/106
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The ampoule insertion process transiently disturbs the
equilibration, and thus useful heat flow rate data were not
obtained for the first ~60 minutes (details below). Heat
flow was sampled at rate of 1 Hz in J/s or W. Optionally,
the heat flow rate vs. time data file can be exported for fur-
ther evaluation, e.g. calculation of total energy in J pro-
duced in time t, compared to baseline.
Bacterial strains and growth medium
The strains used in this study were the reference strains for
MIC determinations as recommended by the CLSI man-
ual [15]. Escherichia coli ATCC25922 was grown on LB
agar plates or broth (Difco, Chemie Brunschwig, Basel,
Switzerland) and Staphylococcus aureus ATCC29213 was
cultivated on BHI agar plates or broth (Difco). The cul-
tures were kept at -80°C in their respective growth media
supplemented with 30% glycerol (Fluka, Buchs, Switzer-
land). Prior to use for the MIC determinations, they were
cultivated on agar plates as recommended by the CLSI [2].
Inoculum preparation
The inoculum preparation was as follows: A single colony
was picked from a fresh plate and incubated overnight at
37°C in the respective growth medium. This culture was
then adjusted with 0.01 M phosphate buffered saline pH
7.4 (PBS, Lab Dr. Bichsel, Interlaken, Switzerland) to an
OD600 of 0.01.
Antibiotics preparation
The 12 antibiotics used in this study for E. coli and S.
aureus were chosen from among those listed in the CLSI
manual [15]. All antibiotics were purchased from Fluka,
Buchs, Switzerland. The required concentrations were pre-
pared in cation-adjusted Mueller-Hinton Broth (MHII,
Mueller Hinton II broth, Difco) by serial dilution from a
stock solution according to the CLSI manual [15]. The
Results section indicates which antibiotics were evaluated
with which bacteria and at what concentrations.
Sample preparation for microcalorimetry
Prior to use, the ampoules and the closures (rubber septa
with integrated metal crimp-seal collars) were washed and
separately sterilized (121°C, 20 min). They were then
aseptically filled with 2.97 ml of MHII with or without
added antibiotic and inoculated with 1% (30 μl) of the
prepared inoculum (as described above). In addition,
blanks were prepared (media alone, no inoculum) and
evaluated calorimetrically to verify that measured heat
flows were in all cases due only to microbial activity.
Prior to inserting ampoules, the thermostat and its calo-
rimeters were equilibrated for at least 45 min at 37°C. The
ampoules were then inserted in the calorimeters and low-
ered into the equilibration position. (Each of the 48 calo-
rimeters is a separate instrument, and each evaluation is
started, recorded and stopped separately.) At 15 min post-
insertion, the ampoules were lowered down to the meas-
uring positions. Then, 45 min later, after a calorimeter's
heat flow signal has regained stability, the actual measure-
ment of the heatflow vs. time started. This time was taken
as time zero for the evaluation of the data and was thus
actually ~1 hour after introducing the inoculum into the
medium at room temperature.
Standard interpretation method
Unless otherwise stated, each standard (non-calorimetric)
experiment was performed in parallel with a calorimeter
ampoule placed in a water bath at 37°C and evaluated
after 24 h incubation using a photometer set at a wave-
length of 600 nm. The sample preparation and the
ampoules used for these experiments were the same as for
the IMC experiments. All experiments, IMC and standard
method, were performed in triplicate.
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